[Cutaneous lupus profundus].
The objective of this studies is to review clinical and laboratory features of lupus panniculitis. The authors report 3 cases of lupus profundus from a group of 70 lupus erythematosus. In both cases the lupus panniculitis presented as subcutaneous infiltrated and indurated nodules. The diagnosis was confirmed on clinical, histological and therapeutic data. The evolution is slow and is characterised by regression of the inflammatory lesions with treatment by antimalarial drugs. The lupus panniculitis has generally a favorable prognosis.
Khalfallah
Narjess
N
Service de médecine interne B, Hôpital Charles Nicolle-Tunis.
Azzabi
Samira
S
Ben Hassine
Lamia
L
Fathallah
Lamia
L
Kooli
Chekib
C
Fazâa
Bessima
B
Hamza
Mohsen
M
Haddad
Ali
A
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D002738:Chloroquine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D015435:Panniculitis, Lupus Erythematosus / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D002738:Chloroquine; D011241:Prednisone
Le lupus cutané profond.